[Thrombocyte substitution in hematologic patients].
Worldwide, platelet transfusions have increased substantially, especially in hematological patients. The prophylactic and therapeutic indications for platelet substitution as well as the choice of platelet preparation are discussed for patients with acute leukemia or aplastic anemia who need the highest platelet support. Here we present our current strategy, i.e., prophylactic transfusions with random platelets in acute leukemia and therapeutic transfusions with filtered random platelets in aplastic anemia patients only.
Wiesneth
M
M
Abteilung für Transfusionsmedizin der Universität Ulm, BRD.
D000208:Acute Disease; D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood* / Q000628:therapy; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D007938:Leukemia / Q000097:blood* / Q000628:therapy; D008212:Lymphocyte Depletion; D010976:Platelet Count; D017713:Platelet Transfusion